Healthpeak Properties, Inc. $DOC Shares Sold by Equity Investment Corp

Key Points

• Equity Investment Corp reduced its Healthpeak Properties stake by 2.3% in the second quarter, selling 177,266 shares but retaining 7.49 million shares valued at approximately $160.2 million. Institutional investors collectively own 93.57% of DOC.
• Analysts maintain a generally cautious outlook, with four Buy ratings and 15 Hold ratings. The consensus rating is Hold, with an average price target of $21.44.
• Healthpeak beat quarterly expectations, reporting EPS of $0.08 versus the $0.03 estimate and revenue of $771.6 million. The company also declared a monthly dividend of $0.1017 per share, implying a roughly 6.0% annualized yield.

Equity Investment Corp lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,487,967 shares of the real estate investment trust's stock after selling 177,266 shares during the period. Healthpeak Properties comprises 3.1% of Equity Investment Corp's holdings, making the stock its 5th largest holding. Equity Investment Corp owned 1.09% of Healthpeak Properties worth $160,242,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in DOC. OneDigital Investment Advisors LLC grew its position in Healthpeak Properties by 3.3% during the second quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock worth $329,000 after buying an additional 493 shares in the last quarter. Clearstead Trust LLC grew its holdings in shares of Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after purchasing an additional 543 shares in the last quarter. CX Institutional increased its position in shares of Healthpeak Properties by 6.1% in the second quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock worth $235,000 after purchasing an additional 633 shares during the period. Fiduciary Trust Co increased its position in shares of Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock worth $264,000 after purchasing an additional 644 shares during the period. Finally, Quadrant Capital Group LLC raised its stake in Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock valued at $721,000 after purchasing an additional 718 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on DOC. Wells Fargo & Company upped their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a report on Wednesday, July 15th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Healthpeak Properties in a research note on Wednesday, August 5th. Royal Bank Of Canada upped their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Cantor Fitzgerald lifted their price objective on Healthpeak Properties from $20.00 to $23.00 and gave the stock a "neutral" rating in a research report on Thursday, August 6th. Finally, Scotiabank raised their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a "sector perform" rating in a report on Wednesday, May 27th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $21.44.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $20.47 on Wednesday. The stock has a market cap of $14.12 billion, a P/E ratio of 58.49, a P/E/G ratio of 3.20 and a beta of 1.01. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.95. The company's 50 day moving average price is $21.35 and its two-hundred day moving average price is $18.95. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm's quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's payout ratio is currently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source